Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

- PMLiVE

UK site a casualty as Pfizer reduces pain R&D

Will shut down Granta Park facility in Cambridge with loss of 120 jobs

Daiichi Sankyo logo

Daiichi Sankyo to shut down German antibody unit U3

Will transfer its operations to a research unit in Japan

Sanofi Espoir Foundation appoints new president

Xavier Darcos succeeds Jean-François Dehecq

Eli Lilly HQ

Lilly says insulin peglispro too risky to pursue

Discontinues development of medicine once tipped as a diabetes blockbuster

Face-to-face beats digital as prescribing influence

But report confirms doctors continue to embrace digital technology

- PMLiVE

Blue Latitude’s industry-first praised at PMEA

Support for Lilly and its Medical Information Cascade wins Innovation Award

- PMLiVE

Alexion’s rare bone disorder therapy rejected by NICE

Draft guidance rules Strensiq does not have a compelling enough evidence base

- PMLiVE

GSK’s severe asthma therapy Nucala gets EU nod

Becomes the first IL-5 inhibitor to be approved in the EU

- PMLiVE

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Lucid team : because you’re worth it!

Lucid group reward the team for an amazing year

Lucid Group Communications Limited

- PMLiVE

Novo Nordisk says Victoza outperforms SGLT2 inhibitors

Comparesthe GLP-1 agonist to Invokana, Jardiance and Farxiga

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links